KALA BIO Files Prospectus Supplement; Counsel's Legal Opinion Attached

What Happened
KALA BIO, Inc. announced that on July 22, 2026 it filed a prospectus supplement under Rule 424(b) relating to an offering of securities under its effective Registration Statement on Form S-3 (File No. 333-295667). The company filed this Form 8-K on July 23, 2026 to furnish the legal opinion regarding the validity of the securities being offered. The opinion is provided by Haynes and Boone, LLP and is attached as Exhibit 5.1 to the filing (with the firm’s consent included as Exhibit 23.1).

Key Details

• Date of prospectus supplement: July 22, 2026.
• Registration statement: Offering made pursuant to the company’s effective Form S-3 (File No. 333-295667).
• Legal opinion: Opinion of Haynes and Boone, LLP furnished as Exhibit 5.1; consent from the counsel is included.
• No offering terms disclosed in this 8-K: The filing does not state the size, price, type of securities, or use of proceeds.

Why It Matters
This filing signals KALA BIO is preparing or conducting a securities offering under its shelf registration. The attached legal opinion is a routine but necessary document confirming counsel’s view on the validity of the securities. For investors, the important next step is to review the prospectus supplement (and any subsequent filings) for the offering size, pricing, and potential dilution—those material details are not included in this 8-K. There are no earnings, management changes, or other financial details reported here.